Quarterly report [Sections 13 or 15(d)]

Unaudited Consolidated Statements of Operations

v3.26.3
Unaudited Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Other revenue $ 0 $ 0 $ 0 $ 1,404
Operating expenses:        
Research and development 212 177 659 780
General and administrative 492 547 1,466 2,955
Total operating expenses 704 724 2,125 3,735
Income (loss) from operations (704) (724) (2,125) (2,331)
Other income:        
Interest income 13 34 48 96
Change in fair value of warrant liabilities 0 (2) 1 14
Total other income 13 32 49 110
Net income (loss) (691) (692) (2,076) (2,221)
Net loss attributable to non-controlling interests 0 (9) 0 (21)
Net income (loss) attributable to Avenue (691) (683) (2,076) (2,200)
Net income (loss) attributable to common stockholders $ (691) $ (683) $ (2,076) $ (2,200)
Net income (loss) per common share attributable to common stockholders, basic and diluted (in dollars per share) $ (0.2) $ (0.21) $ (0.6) $ (0.71)
Weighted average number of common shares outstanding, basic and diluted (in shares) 3,475,687 3,183,558 3,472,315 3,113,464